|
US5965132A
(en)
*
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
DE19845798A1
(de)
*
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
|
AU770381B2
(en)
*
|
1999-01-22 |
2004-02-19 |
Burnham Institute, The |
Homing pro-apoptotic conjugates and methods of using same
|
|
WO2001058240A2
(en)
*
|
2000-02-10 |
2001-08-16 |
Massachusetts Eye And Ear Infirmary |
Photodynamic therapy for treating conditions of the eye
|
|
AU2006203034B2
(en)
*
|
2000-02-10 |
2006-09-07 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
DE10043481A1
(de)
*
|
2000-09-04 |
2002-04-11 |
Vectron Therapeutics Ag Imt |
Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung
|
|
JP2003021631A
(ja)
*
|
2001-05-10 |
2003-01-24 |
Chugai Pharmaceut Co Ltd |
骨転移抑制剤のスクリーニング方法
|
|
EP1432447A2
(en)
*
|
2001-09-27 |
2004-06-30 |
The Board Of Regents, The University Of Texas System |
Combined compositions and methods for tumor vasculature coagulation and treatment
|
|
AP2740A
(en)
*
|
2003-08-01 |
2013-09-30 |
Genentech Inc |
Anti-VEGF antibodies
|
|
US20050106667A1
(en)
*
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
WO2005044853A2
(en)
*
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
EP1533617A1
(en)
*
|
2003-11-19 |
2005-05-25 |
RMF Dictagene S.A. |
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
|
|
WO2006020979A2
(en)
*
|
2004-08-13 |
2006-02-23 |
Yale University |
Factor vii conjugates for selectively treating neovascularization disorders
|
|
MX2007003522A
(es)
*
|
2004-09-24 |
2007-06-11 |
Beth Israel Hospital |
Complicaciones del embarazo.
|
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
|
JP2008523816A
(ja)
*
|
2004-12-15 |
2008-07-10 |
ベス イスラエル ディーコネス メディカル センター |
妊娠合併症の診断および処置に有用な核酸およびポリペプチド
|
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
|
US8642031B2
(en)
|
2006-11-02 |
2014-02-04 |
Acceleron Pharma, Inc. |
Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
|
|
BRPI0717964A2
(pt)
|
2006-11-02 |
2013-12-17 |
Acceleron Pharma Inc |
Receptor e antagonistas de ligante da alk1 e usos dos mesmos.
|
|
US10059756B2
(en)
|
2006-11-02 |
2018-08-28 |
Acceleron Pharma Inc. |
Compositions comprising ALK1-ECD protein
|
|
TWI580694B
(zh)
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
抗-ｖｅｇｆ抗體
|
|
EP3398966A1
(en)
|
2008-05-02 |
2018-11-07 |
Acceleron Pharma, Inc. |
Methods and compositions for modulating angiogenesis and pericyte composition
|
|
US20100082438A1
(en)
*
|
2008-10-01 |
2010-04-01 |
Ronnie Jack Garmon |
Methods and systems for customer performance scoring
|
|
AU2010284433B2
(en)
*
|
2009-08-17 |
2013-12-05 |
Health Research, Inc. |
Combination therapy of cancer with anti-endoglin antibodies and anti-VEGF agents
|
|
US8221753B2
(en)
|
2009-09-30 |
2012-07-17 |
Tracon Pharmaceuticals, Inc. |
Endoglin antibodies
|
|
KR101931820B1
(ko)
*
|
2009-12-09 |
2018-12-21 |
바이엘 파마 악티엔게젤샤프트 |
항―ｃ４.４ａ 항체 및 그의 용도
|
|
CA2827952A1
(en)
*
|
2011-02-23 |
2012-11-01 |
Health Research, Inc. |
Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
|
|
US9255595B2
(en)
*
|
2011-04-29 |
2016-02-09 |
Bae Systems Information And Electronic Systems Integration Inc. |
Optical dome bezel
|
|
UA115789C2
(uk)
|
2012-09-05 |
2017-12-26 |
Трейкон Фармасутікалз, Інк. |
Композиція антитіла до cd105 та її застосування
|
|
CN105408917B
(zh)
|
2013-06-14 |
2019-04-19 |
安捷伦科技有限公司 |
用于便利对象的手动分类的系统和方法
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
US9926375B2
(en)
|
2014-11-12 |
2018-03-27 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
US10155820B2
(en)
|
2014-11-12 |
2018-12-18 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
SG10201911226QA
(en)
|
2015-09-23 |
2020-01-30 |
Genentech Inc |
Optimized variants of anti-vegf antibodies
|
|
RU2607029C1
(ru)
*
|
2015-10-20 |
2017-01-10 |
ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ / ФГБУ "РНЦРХТ" Минздрава России |
ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ КЛЕТОК ЖИВОТНЫХ Mus musculus L. - EN-4C9 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ПРОТИВ ЭНДОГЛИНА (CD105) ЧЕЛОВЕКА
|
|
CN106928359B
(zh)
*
|
2015-12-30 |
2020-10-13 |
广西医科大学 |
一种CD105纳米抗体Nb59
|
|
CN106928355B
(zh)
*
|
2015-12-30 |
2020-09-29 |
广西医科大学 |
一种CD105纳米抗体Nb184
|
|
WO2017223495A1
(en)
|
2016-06-24 |
2017-12-28 |
University Of South Carolina |
Inhibin as targetable regulators of angiogenesis
|
|
EP3900733A1
(en)
|
2020-04-24 |
2021-10-27 |
Derma Innovate S.L. |
Src kinase activators and eng function inhibitors as enhancers of skin homeostasis/regeneration and hair growth
|
|
CN116063496B
(zh)
*
|
2022-08-15 |
2023-10-24 |
营龄(武汉)生物科技有限公司 |
载药的人血白蛋白联合单克隆抗体在制备药物组合物中的用途
|
|
CN115991773B
(zh)
*
|
2022-08-15 |
2023-11-17 |
营龄(武汉)生物科技有限公司 |
一种含有人血白蛋白的药物组合物
|